SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-182492
Filing Date
2018-06-04
Accepted
2018-06-04 07:04:10
Documents
4
Period of Report
2018-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d596069d6k.htm 6-K 9763
2 EX-99.1 d596069dex991.htm EX-99.1 17389
3 GRAPHIC g596069g0604003915361.jpg GRAPHIC 2906
4 GRAPHIC g596069g0604003915705.jpg GRAPHIC 4213
  Complete submission text file 0001193125-18-182492.txt   38366
Mailing Address 60 AVENUE ROCKEFELLER LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 18876852
SIC: 2836 Biological Products, (No Diagnostic Substances)